홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
March 3, 2026
Non-coding RNAs as emerging biomarkers in melanoma
QA
Qamar Abuhassan
MA
Mutaz Jamal Al-khreisat
RR
R. Roopashree
See all
Key Points
Non-coding RNAs act as emerging biomarkers in melanoma, enhancing diagnosis and prognosis.
Significant correlations were identified between non-coding RNA levels and tumor progression in melanoma patients.
Observational analysis across multiple melanoma cases highlighted key non-coding RNAs linked to disease outcomes.
This work suggests possible diagnostic advancements, although further validation in larger cohorts is necessary.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Non-coding RNAs as emerging biomarkers in melanoma | Synapse
Cite This Study
Copy
Abuhassan et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76575badf0bb9e87d92bf
https://doi.org/https://doi.org/10.1016/j.cca.2026.120879